Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

PAHCPAHC
Showing 7 of 10 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in PHIBRO ANIMAL HEALTH CORP A

Qube Research & Technologies Ltd holds 181,127 shares of PAHC (PHIBRO ANIMAL HEALTH CORP A), worth $5.7M as of 2026-Q2. The position was decreased (-13.1% shares). PAHC represents 0.0% of Qube Research & Technologies Ltd's portfolio.

Current Value

$5.7M

Current Shares

181,127

Total Value Change

+$4.5M

Total Shares Change

+126,804

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
181,127
-13.1%
$5.7M0.0%$31.40
0
2026-Q1
Decreased
208,449
-28.6%
$11.5M0.0%$52.27
0
2025-Q4
Increased
291,773
+14.3%
$10.9M0.0%$37.51
32
2025-Q3
Increased
255,353
+40.2%
$10.3M0.0%$39.04
37
2025-Q2
Increased
182,122
+22.6%
$4.7M0.0%$25.51
32
2025-Q1
Increased
148,574
+173.5%
$3.2M0.0%$21.23
43
2024-Q4
New
54,323
-
$1.1M0.0%$20.64
35

Other major holders of PAHC: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used